These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2581900)

  • 1. Characterization of two different antibody specificities recognizing distinct antigenic determinants in free lipid A of Escherichia coli.
    Brade L; Brade H
    Infect Immun; 1985 Jun; 48(3):776-81. PubMed ID: 2581900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and antigenicity of synthetic Escherichia coli lipid A.
    Brade L; Rietschel ET; Kusumoto S; Shiba T; Brade H
    Infect Immun; 1986 Jan; 51(1):110-4. PubMed ID: 2416687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic properties of Chlamydia trachomatis lipopolysaccharide.
    Brade L; Nurminen M; Mäkelä PH; Brade H
    Infect Immun; 1985 May; 48(2):569-72. PubMed ID: 2580795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid A and anti-lipid A.
    Mattsby-Baltzer I; Kaijser B
    Infect Immun; 1979 Mar; 23(3):758-63. PubMed ID: 378836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
    Siber GR; Kania SA; Warren HS
    J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment.
    Brade L; Brandenburg K; Kuhn HM; Kusumoto S; Macher I; Rietschel ET; Brade H
    Infect Immun; 1987 Nov; 55(11):2636-44. PubMed ID: 3666956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding characteristics and cross-reactivity of three different antilipid A monoclonal antibodies.
    Erich T; Schellekens J; Bouter A; Van Kranen J; Brouwer E; Verhoef J
    J Immunol; 1989 Dec; 143(12):4053-60. PubMed ID: 2687375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity of monoclonal antibodies and sera directed against lipid A and lipopolysaccharides.
    Kuhn HM
    Infection; 1993; 21(3):179-86. PubMed ID: 8365817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity and cross-reactivity of monoclonal antibodies reactive with the core and lipid A regions of bacterial lipopolysaccharide.
    Pollack M; Chia JK; Koles NL; Miller M; Guelde G
    J Infect Dis; 1989 Feb; 159(2):168-88. PubMed ID: 2915151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on hemagglutination and hemolysis by escherichia coli antisera.
    NETER E; BERTRAM LF; ZAK DA; MURDOCK MR; ARBESMAN CE
    J Exp Med; 1952 Jul; 96(1):1-15. PubMed ID: 14946324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin.
    Johns M; Skehill A; McCabe WR
    J Infect Dis; 1983 Jan; 147(1):57-67. PubMed ID: 6185599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
    Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
    J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of Shwartzman-inducing activity by antibodies recognizing the Re core or lipid A structures of lipopolysaccharide from Salmonella minnesota R595 and Pseudomonas vesicularis JCM1477.
    Mashimo J; Mizutani T; Mita A; Kasai N
    Microbiol Immunol; 1991; 35(6):423-34. PubMed ID: 1921759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide.
    Brade L; Holst O; Kosma P; Zhang YX; Paulsen H; Krausse R; Brade H
    Infect Immun; 1990 Jan; 58(1):205-13. PubMed ID: 2294050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.
    Bogard WC; Dunn DL; Abernethy K; Kilgarriff C; Kung PC
    Infect Immun; 1987 Apr; 55(4):899-908. PubMed ID: 3549565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants.
    Johns MA; Bruins SC; McCabe WR
    Infect Immun; 1977 Jul; 17(1):9-15. PubMed ID: 69613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of active and passive immunizations with lipid A and salmonella minnesota Re 595 on gram-negative infections in mice.
    Hodgin LA; Drews J
    Infection; 1976; 4(2):5-10. PubMed ID: 789248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response of rabbits to lipid A: influence of immunogen preparation and distribution of various lipid A specificities.
    Kuhn HM
    Infect Immun; 1993 Feb; 61(2):680-8. PubMed ID: 7678589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5.
    Baumgartner JD; O'Brien TX; Kirkland TN; Glauser MP; Ziegler EJ
    J Infect Dis; 1987 Jul; 156(1):136-43. PubMed ID: 2439613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity and function of monoclonal antibodies reactive with discrete structural elements of bacterial lipopolysaccharide.
    Pollack M; Oishi K; Chia J; Evans M; Guelde G; Koles N
    Adv Exp Med Biol; 1990; 256():331-40. PubMed ID: 1691578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.